04.03.25 -- UCB Reaffirms Importance Of Including Women In Clinical Research

As cell and gene therapies (CAGTs) evolve, adaptive strategies are crucial to accelerating development and ensuring timely patient access.

Leveraging incurred sample reanalysis (ISR) in your quality control helps your team mitigate risks, establish regulatory compliance, and instill confidence in your pharmacokinetic modeling.

Discover how one university was able to identify and resolve programmatic gaps in compliance with federal regulations and revitalize its Human Research Protection Program.

Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships.

Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.

Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.

Through strategic planning, adaptive trial execution, and proactive collaboration, TFS successfully navigated the complexities of this early-phase oncology study.

This video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.

Discover versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.

With a focus on small and mid-sized biopharma companies, this premier CRO specializes in delivering innovative solutions in oncology and infectious diseases.

Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes and relatively high costs.